HomeEII • FRA
Eisai Co Ltd
€33.31
Sep 30, 8:34:32 AM GMT+2 · EUR · FRA · Disclaimer
StockDE listed securityJP headquartered
Previous close
€33.20
Day range
€33.31 - €33.31
Year range
€31.16 - €53.80
Market cap
1.71T JPY
Avg Volume
14.00
P/E ratio
-
Dividend yield
-
Primary exchange
TYO
CDP Climate Change Score
A-
Market news
Financials
Income Statement
Revenue
Net income
(JPY)Jun 2024Y/Y change
Revenue
189.03B-4.01%
Operating expense
135.86B6.99%
Net income
10.58B-47.98%
Net profit margin
5.60-45.79%
Earnings per share
——
EBITDA
23.47B-34.41%
Effective tax rate
27.92%—
Total assets
Total liabilities
(JPY)Jun 2024Y/Y change
Cash and short-term investments
303.94B12.86%
Total assets
1.42T8.82%
Total liabilities
500.55B14.43%
Total equity
919.70B—
Shares outstanding
285.52M—
Price to book
0.01—
Return on assets
2.38%—
Return on capital
3.10%—
Net change in cash
(JPY)Jun 2024Y/Y change
Net income
10.58B-47.98%
Cash from operations
-8.58B-167.88%
Cash from investing
3.58B130.91%
Cash from financing
-11.89B23.09%
Net change in cash
-743.00M-138.02%
Free cash flow
-13.97B-16.72%
About
Eisai Co., Ltd. is a Japanese pharmaceutical company headquartered in Tokyo, Japan. It has some 10,000 employees, among them about 1,500 in research. Eisai is listed on the Tokyo Stock Exchange and is a member of the Topix 100 and Nikkei 225 stock indices. Wikipedia
Founded
Dec 6, 1941
Employees
11,067
Search
Clear search
Close search
Google apps
Main menu